MyAverix Finance
LSE · Healthcare
AstraZeneca (AZN)
Drug Manufacturers - General
AstraZeneca (AZN) is listed on LSE in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-24, reported market cap is $215.82B, P/E ratio is 28.17, net margin is 17.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AZN
AstraZeneca (AZN) — FAQ
What is AstraZeneca's market cap?
AstraZeneca (AZN) has a reported market cap of $215.82B (data as of 2026-05-24).
What is AZN's P/E ratio?
The price-to-earnings (P/E) ratio for AstraZeneca (AZN) is 28.17 (data as of 2026-05-24).
Does AstraZeneca pay a dividend?
Dividend yield is not available in the current snapshot for AstraZeneca (AZN). Check the MyAverix Finance app for the latest dividend data.
What sector is AstraZeneca in?
AstraZeneca (AZN) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is AZN listed on?
AZN is listed on LSE.
What is AstraZeneca's net margin?
AstraZeneca (AZN) reports a net margin of 17.2% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.